 Shares of Eidos Therapeutics Inc NASDAQ:EIDX have earned a consensus recommendation of Hold from the ten brokerages that are presently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, two have given a hold recommendation and six have given a buy recommendation to the company. The average ... 